Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Randomized Controlled Trial of Lidocaine Occipital Nerve Blocks to Treat Status Migrainosus in Children/Adolescents

              Author:Szperka, Christina   Marquez de Prado, Blanca   Hsu, Jesse   Gelfand, Amy   Haagen, Dana   Kellier, Danielle   Dlugos, Dennis   Raj, Nichelle   Hershey, Andrew   Farrar, John   

              Session Name:S22: Advances in Migraine and Therapeutics  

              Topic:Headache  

              Program Number:S22.001  

              Author Institution:Children's Hospital of Philadelphia & Perelman School of Medicine at the Univ of PA, Philadelphia, PA  Children's Hospital of Philadelphia, Philadelphia, PA  University of Pennsylvania, Philadelphia, PA  UCSF, San Francisco, CA  Fox Chase Cancer Center, Philadelphia, PA  Cincinnati Childrens Hospital Medical Center, Cincinnati, OH  

              Prevalence and Characteristics of Women with Menstrual Migraine in the 2021 United States National Health & Wellness Survey

              Author:Brown, Joshua   Lewis, Motomori   Jenkins, Aaron   Cirillo, Jessica   Hygge Blakeman, Karin   Yang, Jiyue   Abraham, Lucy   Ailani, Jessica   

              Session Name:S22: Advances in Migraine and Therapeutics  

              Topic:Headache  

              Program Number:S22.002  

              Author Institution:Pfizer, Inc., New York City, NY  Pfizer, Inc., New York, NY  Pfizer R&D UK Ltd, Tadworth, United Kingdom  Medstar Georgetown Neurology, McLean, VA  

              Gaps in Acute Treatment Optimization in Participants with Migraine: Results from the US Cohort of the Chronic Migraine Epidemiology and Outcomes—International (CaMEO-I) Study

              Author:Schwedt, Todd   Buse, Dawn   Hutchinson, Susan   Fanning, Kristina   Schlacher, Casey   Contreras-De Lama, Janette   Lipton, Richard   

              Session Name:S22: Advances in Migraine and Therapeutics  

              Topic:Headache  

              Program Number:S22.003  

              Author Institution:Mayo Clinic, Phoenix, AZ  Albert Einstein College of Medicine, San Diego, CA  Orange County Migraine & Headache, Irvine, CA  MIST Research & Statistical Consulting, Chapel Hill, NC  AbbVie, Highwood, IL  AbbVie, Irvine, CA  Albert Einstein College of Medicine, Bronx, NY  

              Randomized Controlled Trial of a Smartphone-based Preventive Migraine Self-management Program in the Emergency Department Setting: A Promising Teachable Moment

              Author:Minen, Mia   Seng, Elizabeth   Friedman, Benjamin   George, Alexis   Fanning, Kristina   Bostic, Ryan   Powers, Scott   Lipton, Richard   

              Session Name:S22: Advances in Migraine and Therapeutics  

              Topic:Headache  

              Program Number:S22.004  

              Author Institution:NYU Langone Health, New York, NY  Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY  Albert Einstein College of Medicine , New York, NY  MIST Research and Statistical Consulting, Wilmington, NC  Cincinnati Children's Hospital, Cincinnati, OH  Albert Einstein College of Medicine, Bronx, NY  

              Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine: Results from the TANDEM Trial

              Author:Brand-Schieber, Elimor   Lipton, Richard   Blumenfeld, Andrew   Yizeng He, Molly   Smith, Jonathan   Trugman, Joel   de Abreu Ferreira, Rosa   Ailani, Jessica   

              Session Name:S22: Advances in Migraine and Therapeutics  

              Topic:Headache  

              Program Number:S22.005  

              Author Institution:AbbVie, Madison, NJ  Albert Einstein College of Medicine, Bronx, NY  Headache Center of Southern California, Carlsbad, CA  AbbVie, North Chicago, IL  Georgetown University Hospital, McLean, VA